BIOMARIN PHARMACEUTICAL INC reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Novato, CA
SEC filing record 1 source field available
Fiscal year end
31 December
BIOMARIN PHARMACEUTICAL INC has filed 2,724 SEC EDGAR filings since 04 May 1999

SEC filing history

Showing 976-1,000 of 1,000 matching filings.

Per page
25
Current page
40
5

FORM 5

Filing date
14 Feb 2017
Reporting date
31 Dec 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-56595

SANDS CAPITAL MANAGEMENT, LLC SC 13GA NO. 2 12-31-2016 (BIOMARIN PHARMACEUTICAL

Filing date
14 Feb 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-56595

SC 13G/A filing

Filing date
14 Feb 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-56595

SC 13G/A

Filing date
13 Feb 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-56595

SC 13G/A filing

Filing date
10 Feb 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-56595

13G INITIAL ANNUAL FILING (BMRN)

Filing date
02 Feb 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-56595

SC 13G filing

Filing date
30 Jan 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
27 Jan 2017
Reporting date
25 Jan 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-56595

SC 13G/A filing

Filing date
19 Jan 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
12 Jan 2017
Reporting date
10 Jan 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
10 Jan 2017
Reporting date
06 Jan 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
10 Jan 2017
Reporting date
09 Jan 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
03 Jan 2017
Reporting date
29 Dec 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-26727

8-K

Filing date
19 Dec 2016
Reporting date
13 Dec 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-26727

8-K

Filing date
09 Dec 2016
Reporting date
05 Dec 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-26727

8-K CREDIT FACILITY NOV 2016

Filing date
02 Dec 2016
Reporting date
29 Nov 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
29 Nov 2016
Reporting date
25 Nov 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
23 Nov 2016
Reporting date
21 Nov 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
22 Nov 2016
Reporting date
07 Oct 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
18 Nov 2016
Reporting date
16 Nov 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
14 Nov 2016
Reporting date
31 Oct 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
14 Nov 2016
Reporting date
09 Nov 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
09 Nov 2016
Reporting date
07 Nov 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-26727

FORM 10-Q Q3 2016

Filing date
03 Nov 2016
Reporting date
30 Sep 2016
Next action
Verify source filing
4

FORM 4

Filing date
31 Oct 2016
Reporting date
27 Oct 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .